| Evaluation of the Safety, Tolerability and Pharmacokinetics of HY6725 in Healthy Adult Participants (NCT07262281) | Newsoara Biopharma Co., Ltd. | 2026-02-06 |
| Evaluation of the Safety, Tolerability and Pharmacokinetics of HY8931 in Healthy Adult Participants (NCT07281703) | Newsoara Biopharma Co., Ltd. | 2026-01-14 |
| HPP737 in Adult Patients With Plaque Psoriasis (NCT07712731) | Newsoara Biopharma Co., Ltd. | 2025-04-18 |
| HY1272 in Patients With Locally Advanced or Metastatic Solid Tumors or Locally Advanced or Metastatic EGFRm+ NSCLC (NCT06218940) | Newsoara Biopharma Co., Ltd. | 2024-12-01 |
| HPP737 Substance Balance Study in Human (NCT06584058) | Newsoara Biopharma Co., Ltd. | 2024-08-30 |
| HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis. (NCT07712705) | Newsoara Biopharma Co., Ltd. | 2023-04-20 |
| Safety, Tolerance and Pharmacokinetics of THR-1442 in Chinese Healthy Subjects (NCT05369078) | Newsoara Biopharma Co., Ltd. | 2021-12-01 |
| Safety and Efficacy of THR-1442 Compared to Dapagliflozin as Add-on Therapy to Metformin in T2DM (NCT05159882) | Newsoara Biopharma Co., Ltd. | 2021-04-15 |
| Safety and Efficacy of HPP737 in Adult Patients With Plaque Psoriasis (NCT07707141) | Newsoara Biopharma Co., Ltd. | 2021-03-03 |
| Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers (NCT04714294) | Newsoara Biopharma Co., Ltd. | 2020-09-08 |
| Study to Evaluate LB1148 for Return of Gastrointestinal Function, Decrease Post-Operative Ileus (NCT05056935) | Newsoara Biopharma Co., Ltd. | 2019-07-09 |